LeonaBio (LONA) Net Cash Flow (2019 - 2026)
LeonaBio (LONA) reported Net Cash Flow of -$36.4 million for Q1 2026, down 65.53% year-over-year from -$105.7 million in Q1 2025, and down 175.29% quarter-over-quarter from $48.4 million in Q4 2025.
LeonaBio (LONA) Net Cash Flow (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Net Cash Flow data on file, last reported at -$36.4 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$36.4 million, down 65.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (up 112.39% YoY), and the FY2025 annual result was $20.8 million, up 149.44% from the prior year.
- Net Cash Flow retreated to -$36.4 million in Q1 2026 per LONA's latest filing, from $48.4 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $48.4 million in Q4 2025 and troughed at -$36.4 million in Q1 2026.
- A 5-year average of -$4.5 million and a median of -$5.0 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow tumbled 686.75% in 2022, then jumped 268.12% in 2025.
- A 5-year view of Net Cash Flow shows it stood at $9.1 million in 2022, then slumped by 316.39% to -$19.8 million in 2023, then sank by 45.78% to -$28.8 million in 2024, then jumped by 268.12% to $48.4 million in 2025, then tumbled by 175.29% to -$36.4 million in 2026.
- Business Quant data shows LONA's Net Cash Flow at -$36.4 million in Q1 2026, $48.4 million in Q4 2025, and $986000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | -36.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.44 Mn |
| Mar 31, 2026 | -36.44 Mn |
| Dec 31, 2025 | 48.40 Mn |
| Dec 31, 2025 | 48.40 Mn |
| Sep 30, 2025 | 986,000.00 |
| Sep 30, 2025 | 986,000.00 |
| Jun 30, 2025 | -6.56 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Mar 31, 2025 | -22.02 Mn |
| Mar 31, 2025 | -22.02 Mn |
| Dec 31, 2024 | -28.79 Mn |
| Dec 31, 2024 | -28.79 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | 4.23 Mn |
| Jun 30, 2024 | 4.23 Mn |
| Mar 31, 2024 | -12.76 Mn |
| Mar 31, 2024 | -12.76 Mn |
| Dec 31, 2023 | -19.75 Mn |
| Dec 31, 2023 | -19.75 Mn |